Fig. 5From: BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional cultureThe effect of BI-847325, as a selective dual MEK and Aurora kinases inhibitor, on the fundamental cellular and molecular mechanisms including cell cycle, apoptosis, proliferation, invasion, angiogenesis, drug resistance, and differentiation in ATC cellsBack to article page